Robert Sexton brings over two decades of progressive leadership experience in the biopharmaceutical industry and a track record of success in driving growth through groundbreaking product launches. Throughout his distinguished career, Mr. Sexton has consistently championed transformative initiatives at industry leaders like Novartis, Sanofi, and Legend Biotech. His expertise spans across various aspects of drug development, from scientific discovery to successful commercialization. Mr. Sexton's leadership has been instrumental in building high-performing teams and driving successful product launches. Notably, he has held senior roles leading the launch efforts of four first-in-class therapies, including the first commercially approved CAR-T product. These advancements represent a groundbreaking contribution to cancer treatment. These achievements exemplify his ability to translate cutting-edge science into real-world applications that benefit patients. Prior to joining Mustang Bio, Mr. Sexton held leadership positions at Legend Biotech, where he spearheaded critical commercialization efforts. In his previous roles at Novartis, he spearheaded the launch of several blockbuster brands and established new industry standards in patient support and market access. Mr. Sexton's academic background complements his extensive industry experience. He holds a Master of Science in Biotechnology & Enterprise Management from Johns Hopkins University, alongside an MBA in Strategic Marketing Management from Monmouth University. This unique combination equips him with a comprehensive understanding of both the scientific and commercial aspects of drug development.